Cancer Startup Thyme Care Raises Funds at $1 Billion Valuation

Thyme Care Inc., a startup that aims to improve the patient experience for people in cancer treatment, has raised $97 million in a new round of venture capital funding, executives told Bloomberg News.

The latest deal values the Nashville-based company at $1 billion, according to people familiar with the matter who asked not to be named discussing private information. It was reported to be valued at $480 million in its previous funding round last year.